RecruitingNCT06721234
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Sponsor
Sohag University
Enrollment
100 participants
Start Date
Dec 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
Eligibility
Min Age: 19 YearsMax Age: 80 Years
Inclusion Criteria4
- Patients fulfill the International Criteria for Behcet's Disease (ICBD)
- Age above 18 years old
- Patients cooperative and can answer questions
- Patients who are able and willing to give informed consent
Exclusion Criteria5
- Other rheumatological and vascular diseases
- Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
- Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
- Patients who are using aspirin and other platelet active drygs during the previous 6 months
- patients who are not able and willing to give written consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06721234